Moors & Cabot, Inc. Bristol Myers Squibb CO Transaction History

Moors & Cabot, Inc.

$1.96 Billion
Q3 2024

A detailed history of Moors & Cabot, Inc. transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Moors & Cabot, Inc. holds 77,651 shares of BMY stock, worth $4.57 Million. This represents 0.2% of its overall portfolio holdings.

Number of Shares

77,651

Previous 85,105 8.76%

Holding current value

$4.57 Million

Previous $3.53 Million 13.7%

% of portfolio

0.2%

Previous 0.19%

33 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 08, 2024	SELL	$39.66 - $51.75 $295,625 - $385,744	-7,454 Reduced 8.76%	77,651 $4.02 Million
Q2 2024 Aug 09, 2024	SELL	$40.25 - $52.99 $639,331 - $841,693	-15,884 Reduced 15.73%	85,105 $3.53 Million
Q1 2024 May 08, 2024	BUY	$47.98 - $54.4 $80,462 - $91,228	1,677 Added 1.69%	100,989 $5.48 Million
Q4 2023 Feb 14, 2024	SELL	$48.48 - $57.85 $343,335 - $409,693	-7,082 Reduced 6.66%	99,312 $5.1 Million
Q3 2023 Nov 07, 2023	SELL	$57.89 - $64.73 $82,088 - $91,787	-1,418 Reduced 1.32%	106,394 $6.18 Million
Q2 2023 Aug 09, 2023	BUY	$63.71 - $70.74 $111,683 - $124,007	1,753 Added 1.65%	107,812 $6.89 Million
Q1 2023 May 04, 2023	BUY	$65.71 - $74.53 $121,892 - $138,253	1,855 Added 1.78%	106,059 $7.35 Million
Q4 2022 Feb 09, 2023	BUY	$68.48 - $81.09 $522,776 - $619,041	7,634 Added 7.91%	104,204 $7.5 Million
Q4 2022 Feb 06, 2023	SELL	$68.48 - $81.09 $332,059 - $393,205	-4,849 Reduced 4.78%	96,570 $6.95 Million
Q3 2022 Nov 07, 2022	BUY	$0.13 - $76.84 $105 - $62,394	812 Added 0.81%	101,419 $7.21 Million
Q2 2022 Aug 08, 2022	SELL	$72.62 - $79.98 $220,619 - $242,979	-3,038 Reduced 2.93%	100,607 $7.75 Million
Q1 2022 May 13, 2022	BUY	$61.48 - $73.72 $106,975 - $128,272	1,740 Added 1.71%	103,645 $7.57 Million
Q4 2021 Feb 14, 2022	SELL	$53.63 - $62.52 $178,963 - $208,629	-3,337 Reduced 3.17%	101,905 $6.35 Million
Q3 2021 Dec 08, 2021	BUY	$59.17 - $69.31 $3.89 Million - $4.56 Million	65,752 Added 166.5%	105,242 $6.25 Million
Q3 2021 Nov 05, 2021	SELL	$59.17 - $69.31 $3.78 Million - $4.43 Million	-63,881 Reduced 61.8%	39,490 $678,000
Q2 2021 Aug 10, 2021	SELL	$61.91 - $67.42 $555,580 - $605,027	-8,974 Reduced 7.99%	103,371 $6.91 Million
Q1 2021 May 12, 2021	SELL	$59.34 - $66.74 $388,914 - $437,413	-6,554 Reduced 5.51%	112,345 $7.1 Million
Q4 2020 Feb 11, 2021	BUY	$57.74 - $65.43 $215,254 - $243,923	3,728 Added 3.24%	118,899 $7.39 Million
Q3 2020 Nov 09, 2020	BUY	$57.43 - $63.64 $161,033 - $178,446	2,804 Added 2.5%	115,171 $6.94 Million
Q2 2020 Aug 13, 2020	BUY	$54.82 - $64.09 $757,502 - $885,595	13,818 Added 14.02%	112,367 $6.63 Million
Q1 2020 May 12, 2020	SELL	$46.4 - $67.43 $316,772 - $460,344	-6,827 Reduced 6.48%	98,549 $5.51 Million
Q4 2019 Jan 28, 2020	SELL	$49.21 - $64.19 $661,726 - $863,162	-13,447 Reduced 11.32%	105,376 $6.76 Million
Q3 2019 Oct 22, 2019	BUY	$42.77 - $50.71 $434,115 - $514,706	10,150 Added 9.34%	118,823 $6.01 Million
Q2 2019 Jul 18, 2019	BUY	$44.62 - $49.34 $1.92 Million - $2.12 Million	42,926 Added 65.29%	108,673 $4.94 Million
Q1 2019 May 06, 2019	SELL	$45.12 - $53.8 $2.97 Million - $3.54 Million	-65,747 Reduced 50.0%	65,747 $3.15 Million
Q1 2019 May 01, 2019	BUY	$45.12 - $53.8 $3.23 Million - $3.86 Million	71,656 Added 119.75%	131,494 $6.3 Million
Q4 2018 Feb 13, 2019	SELL	$48.76 - $63.23 $100,494 - $130,317	-2,061 Reduced 3.33%	59,838 $3.11 Million
Q3 2018 Nov 14, 2018	SELL	$55.19 - $62.25 $104,474 - $117,839	-1,893 Reduced 2.97%	61,899 $3.84 Million
Q2 2018 Aug 14, 2018	SELL	$50.53 - $62.98 $164,677 - $205,251	-3,259 Reduced 4.86%	63,792 $3.54 Million
Q1 2018 May 18, 2018	SELL	$59.92 - $68.98 $740,731 - $852,730	-12,362 Reduced 15.57%	67,051 $4.24 Million
Q4 2017 Feb 13, 2018	SELL	$59.94 - $65.35 $53,706 - $58,553	-896 Reduced 1.12%	79,413 $4.86 Million
Q3 2017 Nov 16, 2017	BUY	$55.23 - $63.74 $231,689 - $267,389	4,195 Added 5.51%	80,309 $5.12 Million
Q2 2017 Aug 15, 2017	BUY	N/A	76,114	76,114 $4.25 Million

Others Institutions Holding BMY

# of Institutions

2,533

Shares Held

1.47B

Call Options Held

31.6M

Put Options Held

35M

View Full List

About BRISTOL MYERS SQUIBB CO

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $125B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

More about BMY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Moors & Cabot, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Moors & Cabot, Inc. with notifications on news.

Account